Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.

Related Keywords

Japan ,Canada ,Florida ,United States ,Switzerland ,Canadian ,Japanese ,Swiss ,Farzin Haque ,Greg Keenan ,Stacy Ku ,Andrea Christopher ,Joe Miller ,Peter Greenleaf ,Maury Raycroft ,Investor Relations For Aurinia Pharmaceuticals ,Exchange Commission ,Nasdaq ,Aurinia Pharmaceuticals First Quarter ,Head Of Corporate Communications ,Aurinia Pharmaceuticals Inc ,Aurinia Pharmaceuticals ,Call Transcript May ,Corporate Communications ,Investor Relations ,Chief Executive Officer ,Chief Financial Officer ,Chief Medical ,Lupus Awareness ,Highest Rates ,Stomach Cancer ,Cheapest Cities To Retire ,